›
^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersTEST:UltraSEEK® Melanoma Panel
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Agena BioType:
Laboratory Developed Test
Related tests:
The UltraSEEK® Melanoma Panel enables study of disease progression and resistance in melanomas. Detects more than 55 clinically relevant variants across 13 genes including BRAF, KIT and NRAS. Identifes variants at as low as 0.1% variant allele frequency.
Uses as little as 10 ng of cfDNA. 1 hour of hands-on time and 8 hours of total time.
Cancer:
Melanoma
Gene:
BRAF (B-raf proto-oncogene), KIT (KIT proto-oncogene, receptor tyrosine kinase), NRAS (Neuroblastoma RAS viral oncogene homolog)
BRAF (B-raf proto-oncogene), KIT (KIT proto-oncogene, receptor tyrosine kinase), NRAS (Neuroblastoma RAS viral oncogene homolog)
